Presence of Retinal Fluid

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Presence of Retinal Fluid trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT07074054

Aflibercept 8 mg for nAMD: Early Anatomical and Functional Changes

Neovascular age-related macular degeneration (nAMD) is one of the main causes of irreversible vision loss in older people worldwide. the central role of vascul…

Italy40 participantsStarted 2024-04-15